NASDAQ:CDNA

CareDx - CDNA Stock Forecast, Price & News

$17.02

-0.08 (-0.47%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $16.96
▼
$17.77
50-Day Range: $16.06
▼
$26.39
52-Week Range: $15.66
▼
$75.92

Volume: 745,819 shs
Average Volume: 865,644 shs
Market Capitalization: $909.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $56.50

CareDx MarketRank™ Forecast

Analyst Rating: Buy
3.33 Rating Score
Upside/Downside: 232.0% Upside
$56.50 Price Target
Short Interest: Bearish
7.28% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.66
Upright™ Environmental Score
News Sentiment: 0.65
Based on 11 Articles This Week
Insider Trading: Selling Shares
$62,546 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.54) to ($1.05) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Medical Sector

634th out of 1,095 stocks

Medical Laboratories Industry

17th out of 30 stocks

3.7

Analyst's Opinion

Consensus Rating
CareDx has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $56.50, CareDx has a forecasted upside of 232.0% from its current price of $17.02.
Amount of Analyst Coverage
CareDx has received no research coverage in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
7.28% of the outstanding shares of CareDx have been sold short.
Short Interest Ratio / Days to Cover
CareDx has a short interest ratio ("days to cover") of 4.9.
Change versus previous month
Short interest in CareDx has recently increased by 7.16%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
CareDx does not currently pay a dividend.
Dividend Growth
CareDx does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
CareDx has received a 61.52% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "DNA sequencers", "Genomics analysis tools", and "Patient flow management systems" products. See details.
Environmental Sustainability
The Environmental Impact score for CareDx is -0.66.

2.6

News and Social Media Coverage

News Sentiment
CareDx has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 11 news articles for CareDx this week, compared to 8 articles on an average week.
Search Interest
Only 1 people have searched for CDNA on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
7 people have added CareDx to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CareDx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $62,546.00 in company stock.
Percentage Held by Insiders
Only 4.60% of the stock of CareDx is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for CareDx are expected to grow in the coming year, from ($1.54) to ($1.05) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CareDx is -12.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of CareDx is -12.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
CareDx has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About CareDx (NASDAQ:CDNA) Stock

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Stock News Headlines

September 29, 2022 | businesswire.com

CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care - Business Wire

September 29, 2022 | finance.yahoo.com

CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care

September 28, 2022 | fool.com

CareDx, Inc. (NASDAQ: CDNA)

September 28, 2022 | benzinga.com

CareDx, Inc. Investor News: Robbins LLP is Investigating CareDx, Inc. (CDNA) on Behalf of Shareholders

September 27, 2022 | businesswire.com

Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions - Business Wire

September 27, 2022 | finance.yahoo.com

Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions

September 26, 2022 | businesswire.com

CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List - Business Wire

September 26, 2022 | finance.yahoo.com

CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List

September 23, 2022 | americanbankingnews.com

CareDx (NASDAQ:CDNA) Sees Unusually-High Trading Volume

September 21, 2022 | finance.yahoo.com

CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference - Yahoo Finance

September 21, 2022 | uk.investing.com

Cathie Wood Cuts $32M From Healthcare Company In Which Amazon Is Reportedly Interested By Benzinga - Investing.com UK

September 19, 2022 | businesswire.com

CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference - Business Wire

September 19, 2022 | finance.yahoo.com

CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference

September 14, 2022 | benzinga.com

CareDx (NASDAQ:CDNA), Block (NYSE:SQ) – Cathie Wood's Ark Invest Adds $7M Of Bitcoin-Focused Block Shares - Benzinga

September 14, 2022 | businesswire.com

CareDx Celebrates 1 Million Organ Transplants and 100000 Patient Milestone - Business Wire

September 14, 2022 | finance.yahoo.com

CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone

September 13, 2022 | nasdaq.com

Icon PLC (ICLR) Surges 3%: Is This an Indication of Further Gains? - Nasdaq

September 12, 2022 | businesswire.com

CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society - Business Wire

September 12, 2022 | finance.yahoo.com

CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society

September 7, 2022 | streetinsider.com

Form 8-K CareDx, Inc. For: Sep 07 - StreetInsider.com

August 31, 2022 | markets.businessinsider.com

Cathie Wood Loads Up $3M In This Precision Medicine Firm's Shares Despite Bleak Q2 Results

August 31, 2022 | benzinga.com

CareDx (CDNA) – SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CareDx, Inc - Benzinga

August 30, 2022 | fool.com

Cathie Wood Goes Bargain-Shopping: 3 Stocks She Just Bought - The Motley Fool

August 30, 2022 | benzinga.com

CareDx (CDNA) – Cathie Wood's Ark Invest Adds $3M In CareDx Shares Despite Bleak Q2 Results - Benzinga

August 25, 2022 | reuters.com

CDNA.O - CareDx Inc | Stock Price & Latest News | Reuters

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Company Calendar

Last Earnings: 8/04/2022
Today: 10/02/2022
Next Earnings (Estimated): 10/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CDNA
CUSIP: N/A
CIK: 1217234
Web: www.caredxinc.com
Phone: (415) 287-2300
Fax: 415-287-2450
Employees: 633
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $56.50
High Stock Price Forecast: $87.00
Low Stock Price Forecast: $37.00
Forecasted Upside/Downside: +232.0%
Consensus Rating: Buy
Rating Score (0-4): 3.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.32)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-30,660,000.00
Net Margins: -22.04%
Pretax Margin: -22.40%
Return on Equity: -15.09%
Return on Assets: -12.52%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.15
Quick Ratio: 4.91

Sales & Book Value

Annual Sales: $296.40 million
Price / Sales: 3.07
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $8.82 per share
Price / Book: 1.93

Miscellaneous

Outstanding Shares: 53,460,000
Free Float: 50,999,000
Market Cap: $909.89 million
Optionable: Optionable
Beta: 1.02

Key Executives

Dr. Reginald Seeto (Age 50)
Pres, CEO & Director
Comp: $1.51M

Ms. Sasha King M.B.A. (Age 36)
Chief Marketing Officer & Franchise Head of Kidney Transplant
Comp: $628.87k

Dr. Peter Maag Ph.D. (Age 55)
Exec. Director
Comp: $791.45k

Mr. Marcel Konrad (Age 46)
Sr. VP of Fin. & Accounting
Comp: $167.96k

Mr. Alexander L. Johnson (Age 47)
Chief Bus. Officer & Head of Testing Services
Comp: $716.54k

Mr. Ankur Dhingra (Age 46)
Consultant
Comp: $909.26k

Mr. Abhishek Jain (Age 46)
Interim CFO, VP, Corp. Controller, Principal Financial Officer & Principal Accounting Officer

Mr. Ian Cooney
VP of Investor Relations

Mr. Abraham Ronai Esq.
Gen. Counsel

Dr. Mickey Y. Kim M.D.
Sr. VP of Corp. Devel. & Strategy

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CDNA Stock - Frequently Asked Questions

Should I buy or sell CareDx stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last year. There are currently 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CDNA shares.
View CDNA analyst ratings or view top-rated stocks.
What is CareDx's stock price forecast for 2022?: 3 analysts have issued 12 month price objectives for CareDx's shares. Their CDNA share price forecasts range from $37.00 to $87.00. On average, they anticipate the company's share price to reach $56.50 in the next year. This suggests a possible upside of 232.0% from the stock's current price.
View analysts price targets for CDNA or view top-rated stocks among Wall Street analysts.
How have CDNA shares performed in 2022?: CareDx's stock was trading at $45.48 at the beginning of the year. Since then, CDNA stock has decreased by 62.6% and is now trading at $17.02.
View the best growth stocks for 2022 here.
When is CareDx's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our CDNA earnings forecast.
How were CareDx's earnings last quarter?: CareDx, Inc (NASDAQ:CDNA) issued its quarterly earnings data on Thursday, August, 4th. The company reported ($0.41) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.11. The firm earned $80.63 million during the quarter, compared to analysts' expectations of $81.85 million. CareDx had a negative trailing twelve-month return on equity of 15.09% and a negative net margin of 22.04%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.04) earnings per share.
What guidance has CareDx issued on next quarter's earnings?: CareDx issued an update on its FY 2022 earnings guidance on Thursday, August, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $325.00 million-$335.00 million, compared to the consensus revenue estimate of $337.92 million.

What other stocks do shareholders of CareDx own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).
What is CareDx's stock symbol?: CareDx trades on the NASDAQ under the ticker symbol "CDNA."
How do I buy shares of CareDx?: Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is CareDx's stock price today?: One share of CDNA stock can currently be purchased for approximately $17.02.
How much money does CareDx make?: CareDx (NASDAQ:CDNA) has a market capitalization of $909.89 million and generates $296.40 million in revenue each year. The company earns $-30,660,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis.
How many employees does CareDx have?: The company employs 633 workers across the globe.
How can I contact CareDx?: CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.

This page (NASDAQ:CDNA) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CareDx - CDNA Stock Forecast, Price & News

CareDx MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows